Coherus Biosciences reported $43.6M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 508.97B 46.71B Nov/2026
Acadia Pharmaceuticals USD 3.57B 100M Nov/2026
Akebia Therapeutics USD 427M 297M Dec/2025
ALKERMES USD 7.43B 629M Nov/2026
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
Amarin USD 290M 51M Dec/2025
Amgen USD 247.94B 20.06B Nov/2026
Baxter International USD 12.41B 1.4B Sep/2026
Biogen USD 33.38B 1.48B Sep/2026
BioMarin Pharmaceutical USD 10.68B 936M Nov/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 1.09T 40.33B Sep/2026
Fujifilm JPY 4.36T 355.33B Nov/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
Merck USD 375.59B 17.09B Nov/2026
Perrigo USD 2.17B 31M Nov/2026
Pfizer USD 165.12B 1.71B Nov/2026
Sarepta Therapeutics USD 1.65B 276M Nov/2026
Teva Pharmaceutical Industries USD 153.58B 106.85B Nov/2026
Vertex Pharmaceuticals USD 140.44B 7.93B Nov/2026
Xencor USD 2.14B 281M Nov/2026
Zoetis USD 37.6B 8.74B Nov/2026